# Jérôme Boursier

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jerome-boursier/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,260 |
| Field | Liver Disease Diagnosis and Treatment |
| h-index | 70 |
| i10-index | 187 |
| Last Known Institution | Centre Hospitalier Universitaire d'Angers |
| OpenAlex ID | https://openalex.org/A5065731342 |
| ORCID iD | https://orcid.org/0000-0002-7282-1436 |
| Works | 469 |

## Researcher papers

Showing 12 of 13.

- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease-3/)
- [Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial](https://scholariq.org/papers/obeticholic-acid-for-the-treatment-of-non-alcoholic-steatohepatitis-interim/)
- [Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening](https://scholariq.org/papers/elafibranor-an-agonist-of-the-peroxisome-proliferator-activated-receptor-and/)
- [Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis](https://scholariq.org/papers/tirzepatide-for-metabolic-dysfunction-associated-steatohepatitis-with-liver/)
- [A multisociety Delphi consensus statement on new fatty liver disease nomenclature](https://scholariq.org/papers/a-multisociety-delphi-consensus-statement-on-new-fatty-liver-disease-2/)
- [FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study](https://scholariq.org/papers/fibroscan-ast-fast-score-for-the-non-invasive-identification-of-patients-with/)
- [Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis](https://scholariq.org/papers/diagnostic-accuracy-of-non-invasive-tests-for-advanced-fibrosis-in-patients-with/)
- [Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials](https://scholariq.org/papers/selonsertib-for-patients-with-bridging-fibrosis-or-compensated-cirrhosis-due-to/)
- [Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis](https://scholariq.org/papers/transcriptomic-profiling-across-the-nonalcoholic-fatty-liver-disease-spectrum/)
- [Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis](https://scholariq.org/papers/diagnostic-accuracy-of-elastography-and-magnetic-resonance-imaging-in-patients/)
- [Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis](https://scholariq.org/papers/enhanced-liver-fibrosis-test-for-the-non-invasive-diagnosis-of-fibrosis-in/)

## Researcher topics

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

## Researcher university

- [Centre Hospitalier Universitaire d'Angers](https://scholariq.org/institutions/centre-hospitalier-universitaire-d-angers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.